Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06003621
Title Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients (MoST-TAP)
Acronym MoST-TAP
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Omico
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.